Androxal Shows Highly Statistically Significant Positive,Effects in Men with

[Lokedogg]

Androxal Shows Highly Statistically Significant Positive,Effects in Men with Secondary Hypogonadism Repros Therapeutics Inc. (NasdaqGM:RPRX) announced topline results of a six month U.S. Phase 3 study of Androxal(TM), an oral drug being developed to restore normal testicular function in men with secondary hypogonadism. Further, Androxal demonstrates non-inferiority in all the endpoints of the study, compared to Androgel(R), a cream which is the leading treatment for low testosterone. read more: http://www.bio-medicine.org/medicine...onadism-451-1/

[HUGEmiller]

I heard that androgel is nonethin' but a pain in the ass....a dude I met was on it for legit reasons and he said he had to be on such a high dose that it would just irritate his skin.

Glad they are progressing.

[SoreButtCheeks]

things are looking good for Androxal's eventual launch, there's normally some news released every 3 months or so to keep investors happy.